Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs J B Hunt Transport Services Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while J B Hunt Transport Services Inc trades at $229.59 (market cap $21.45B). The key difference: J B Hunt Transport Services Inc is far larger — about 3.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and J B Hunt Transport Services Inc for 46 Days on average.
| IOVA | JBHT | |
|---|---|---|
Market Cap | $6.04B | $21.45B |
Volume | 14,805,993 | 1,028,680 |
Sector | Health | Industrials |
52-Week High | $14.82 | $298.41 |
52-Week Low | $1.81 | $137.09 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $5.97B | $22.59B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JBHT trades at $229.26, up 2.97% today, amid a bearish technical signal but strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue has stabilized around $12B, while profitability metrics like ROE (18.45%) and net margin (5.31%) remain solid. However, rising costs and ongoing securities litigation investigations present headwinds.
The outlook is mixed: Wall Street's consensus price target of $289.40 implies significant upside, but near-term pressure from fuel costs and legal overhangs may limit gains. Investors should weigh strong fundamentals against operational risks and market sentiment shifts ahead of Q3 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
